US patent attorneys shift PTAB strategy given changing policies
By Nick Robertson ( August 26, 2025, 21:23 GMT | Insight) -- Patent practitioners told MLex the rapidly changing discretionary denial policies at the US Patent Trial and Appeal Board have shaken their confidence in the board’s decisions, with some now telling clients not to pursue inter partes review.Frequent changes to the institution process at the US Patent Trial and Appeal Board this year have led some patent practitioners to warn their clients against pursuing inter partes reviews, they told MLex. Meanwhile, the changes are giving patent owners newfound strength in front of the board....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.